Aurobindo Pharma USA Inc

Form 483

East Windsor, New Jersey, United StatesFEI 3008460374Issued July 29, 2011

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3008460374.

Observations6

Issue DateJuly 29, 2011

StatusNo Warning Letter

Related Inspections5

Establishment Details

Firm: Aurobindo Pharma USA Inc
Location: East Windsor, New Jersey, United States
FEI Number: 3008460374
Product Type: Drugs
Issue Date: July 29, 2011
Country: United States

Inspection History, 2011 to 2026

NAI3

VAI1

OAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Aurobindo Pharma USA Inc FDA Form 483, East Windsor, New Jersey, July 29, 2011